According to the Zhitong Finance App, Nanhua Biotech (000504.SZ) issued an announcement. On July 12, 2023, the company received the “Notice of Opinions from the Review Center on Nanhua Biomedical Co., Ltd.'s Application for Issuance of Shares to Specific Targets” issued by the Shenzhen Stock Exchange Listing Review Center. The issuance and listing review agency of the Shenzhen Stock Exchange reviewed the company's application documents for the issuance of shares to specific targets and found that the company met the issuance conditions, listing conditions, and information disclosure requirements. In the future, the Shenzhen Stock Exchange will report it to the China Securities Regulatory Commission to complete the relevant registration procedures in accordance with the regulations.
南华生物(000504.SZ)向特定对象发行股票申请获深交所审核通过
Nanhua Biotech (000504.SZ)'s application to issue shares to a specific target was approved by the Shenzhen Stock Exchange
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.